LCA partners with GRAIL, UCL, and ULCH on Newly Announced SUMMIT Study

2018-12-04T00:24:30+00:00December 4th, 2018|Hot Topics, News|

Monday, December 3, 2018 –Today, Lung Cancer Alliance, in collaboration with GRAIL, Inc., a healthcare company focused on the early detection of cancer, UCL (University College London) and University College London Hospitals National Health Service (NHS) Foundation Trust (UCLH) announced plans to initiate the SUMMIT study in early 2019. SUMMIT, which will be conducted in the United Kingdom, is a prospective, observational, longitudinal, cohort study designed to enroll approximately 50,000 men and women age 50 to 77 years who do [...]

No announcement available or all announcement expired.